Anti-cardiac troponin Autoantibodies are specific to the conformational epitopes formed by cardiac troponin i and troponin t in the ternary troponin complex

Clinical Chemistry

Volumn 63, Issue 1, 2017, Pages 343-350

  Vylegzhanina, Alexandra V ^a   Kogan, Alexander E ^a,b   Katrukha, Ivan A ^a,b   Antipova, Olga V ^b   Kara, Andrey N ^b   Bereznikova, Anastasia V ^a,b   Koshkina, Ekaterina V ^c   Katrukha, Alexey G ^a,b  

^a HyTest Ltd   (Finland)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c 67th City Hospital   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; EPITOPE; MONOCLONAL ANTIBODY; TROPONIN C; TROPONIN C AUTOANTIBODY; TROPONIN I; TROPONIN I AUTOANTIBODY; TROPONIN T; TROPONIN T AUTOANTIBODY; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; CARDIAC PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GEL FILTRATION CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; IMMUNODETECTION; IMMUNOREACTIVITY; SYMPTOM; ACUTE DISEASE; ADULT; ANTIGEN ANTIBODY REACTION; BLOOD; HEART INFARCTION; IMMUNOLOGY; MIDDLE AGED; NORMAL HUMAN; YOUNG ADULT;

ACUTE DISEASE; ADULT; ANTIGEN-ANTIBODY REACTIONS; AUTOANTIBODIES; EPITOPES; HEALTHY VOLUNTEERS; HUMANS; IMMUNOASSAY; MIDDLE AGED; MYOCARDIAL INFARCTION; TROPONIN I; TROPONIN T; YOUNG ADULT;

EID: 85008516909     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2016.261602     Document Type: Article

References (22)

1. Katrukha IA. Human cardiac troponin complex. Structure and functions. Biochem Biokhimiia 2013;78:1447-65.
2. Wu AHB, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999;45:1104-21.
3. Eriksson S, Junikka M, Laitinen P, Majamaa-Voltti K, Alfthan H, Pettersson K. Negative interference in cardiac troponin I immunoassays from a frequently occurring serum and plasma component. Clin Chem 2003;49:1095-104.
4. Eriksson S, Junikka M, Pettersson K. An interfering component in cardiac troponin I immunoassays-Its nature and inhibiting effect on the binding of antibodies against different epitopes. Clin Biochem 2004;37:472-80.
5. Bohner J, von Pape KW, Hannes W, Stegmann T. Falsenegative immunoassay results for cardiac troponin I probably due to circulating troponin I autoantibodies. Clin Chem 1996;42:2046.
6. Fortgens PH, Omar F. Cardiac troponin T quantitative assay failure as a result of antibody interference. Afr J Lab Med 2013;2:3.
7. Eriksson S, Halenius H, Pulkki K, Hellman J, Pettersson K. Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies. Clin Chem 2005;51:839-47.
8. Eriksson S, Hellman J, Pettersson K. Autoantibodies against cardiac troponins. N Engl J Med 2005;352:98-100.
9. Adamczyk M, Brashear RJ, Mattingly PG. Circulating cardiac Troponin-I autoantibodies in human plasma and serum. Ann NY Acad Sci 2009;1173:67-74.
10. Pettersson K, Eriksson S, Wittfooth S, Engström E, Nieminen M, Sinisalo J. Autoantibodies to cardiac troponin associate with higher initial concentrations and longer release of troponin I in acute coronary syndrome patients. Clin Chem 2009;55:938-45.
11. Savukoski T, Twarda A, Hellberg S, Ristiniemi N, Wittfooth S, Sinisalo J, et al. Epitope specificity and IgG subclass distribution of autoantibodies to cardiac troponin. Clin Chem 2013;59:512-8.
12. Adamczyk M, Brashear RJ, Mattingly PG. Coprevalence of autoantibodies to cardiac troponin I and T in normal blood donors. Clin Chem 2010;56:676-7.
13. Adamczyk M, Brashear RJ, Mattingly PG. Prevalence of autoantibodies to cardiac troponin T in healthy blood donors. Clin Chem 2009;55:1592-3.
14. Wu AHB. Analytical issues for clinical use of cardiac troponin. In: Morrow DA, editor. Cardiovascular biomarkers. Totowa (NJ): Humana Press; 2006. p 27-41.
15. Bates KJ, Hall EM, Fahie-Wilson MN, Kindler H, Bailey C, Lythall D, et al. Circulating immunoreactive cardiac troponin forms determined by gel filtration chromatography after acute myocardial infarction. Clin Chem 2010;56:952-8.
16. Seferian KR, Tamm NN, Semenov AG, Tolstaya AA, Koshkina EV, Krasnoselsky MI, et al. Immunodetection of glycosylated NT-proBNP circulating in human blood. Clin Chem 2008;54:866-73.
17. Eriksson S, Ilva T, Becker C, Lund J, Porela P, Pulkki K, et al. Comparison of cardiac troponin I immunoassays variably affected by circulating autoantibodies. Clin Chem 2005;51:848-55.
18. Tate JR, Bunk DM, Christenson RH, Katrukha A, Noble JE, Porter RA, et al. Standardisation of cardiac troponin I measurement: past and present. Pathology 2010;42:402-8.
19. Takeda S, Yamashita A, Maeda K, Maéda Y. Structure of the core domain of human cardiac troponin in the Ca (2+)-saturated form. Nature 2003;424:35-41.
20. Goser S, Andrassy M, Buss SJ, Leuschner F, Volz CH, Ottl R, et al. Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 2006;114:1693-702.
21. Kaya Z, Goser S, Buss SJ, Leuschner F, Ottl R, Li J, et al. Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis. Circulation 2008;118:2063-72.
22. Leuschner F, Li J, Göser S, Reinhardt L, Ottl R, Bride P, et al. Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction. Eur Heart J 2008;29:1949-55.